High CD95 expression of BAL lymphocytes predicts chronic course in patients with sarcoidosis

Respirology

Volumn 12, Issue 6, 2007, Pages 869-873

  Ozdemir, Ozlem Kumbasar ^a   Celik, Gokhan ^a   Dalva, Klara ^a   Ulger, Fusun ^a   Elhan, Atilla ^a   Beksac, Meral ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

CD45RO; CD95; Prognosis; Sarcoidosis

Indexed keywords

BETA1 INTEGRIN; CD45 ANTIGEN; CD45RO ANTIGEN; FAS ANTIGEN;

ADULT; ARTICLE; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; LUNG LAVAGE; MALE; PERIPHERAL LYMPHOCYTE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ADULT; ANTIGENS, CD29; ANTIGENS, CD45; ANTIGENS, CD95; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; PROGNOSIS; ROC CURVE; SARCOIDOSIS, PULMONARY;

EID: 35748985247     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2007.01151.x     Document Type: Article

References (20)

1. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF et al. ATS/ERS/WASOG statement on sarcoidosis. SarcoidosisVasc. Diffuse. Lung Dis. 1999 16 : 149 73.
2. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 1997 157 : 1601 5.
3. Planck A, Eklund A, Grunewald J. Inflammatory BAL fluid and serum parameters in HLA DR 17 positive vs DR17 negative patients with pulmonary sarcoidosis. Sarcoidosis Vasc. DiffuseLung Dis. 2001 18 : 64 9.
4. Kunitake R, Kuwano K, Miyazaki H, Hagimoto N, Nomoto Y et al. Apoptosis in the course of granulomatous inflammation in pulmonary sarcoidosis. Eur. Respir. J. 1999 13 : 1329 37.
5. Agostini C, Adami F, Semenzato G. New pathogenetic insights into the sarcoid granuloma. Curr. Opin. Rheumatol. 2000 12 : 71 6.
6. Agostini C, Zambello R, Sancetta R, Cerutti A, Milani A et al. Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am. J. Respir. Crit. Care Med. 1996 15 : 1359 67.
7. Shikuwa C, Kadota J, Mukae H, Iwashita T, Kaida H et al. High concentrations of soluble Fas ligand in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. Respiration 2002 69 : 242 6.
8. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1983 143 : 29 36.
9. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983 148 : 839.
10. Judson MA, Baughman RP, Thompson BW, Teirstein AS, Terrin ML et al. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc. DiffuseLung Dis. 2003 20 : 204 11.
11. Stridh H, Planck A, Gigliotti D, Eklund A, Grunewald J. Apoptosis resistant bronchoalveolar lavage (BAL) fluid lymphocytes in sarcoidosis. Thorax 2002 57 : 897 901.
12. Yamana K, Bilim V, Hara N, Kashara T, Itoi T et al. Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression. Br. J. Cancer 2005 93 : 544 51.
13. Zodelava M, Datikashvili-David I. Prognostic significance of apoptosis-related CD95 antigen expression in patients with nonHodgkin lymphoma. Georgian Med. News 2005 120 : 37 9.
14. Min YJ, Lee JH, Choi SJ, Chi HS, Lee JS et al. Prognostic significance of Fas (CD95) and TRAIL receptors (DR4/DR5) expression in acute myelogenous leukemia. Leuk. Res. 2004 28 : 359 65.
15. Botti C, Buglioni S, Benevolo M, Giannarelli D, Papaldo P et al. Altered expression of Fas system is related to adverse clinical outcome in stage I-II breast cancer patients with adjuvant anthracycline-based chemotherapy. Clin. Cancer Res. 2004 10 : 1360 5.
16. Petersen BL, Rengtred B, Bank MI, Carstensen H. High expression of markers of apoptosis in Langerhans cell histiocytosis. Histopathology 2003 42 : 186 93.
17. Baris YS, Yildiz L, Senturk N, Andemir B. Fas (CD95) and bcl-2 expression in active skin lesions of Behcet's disease. J. Eur. Acad. Dermatol. Venereol. 2005 19 : 569 72.
18. Iida K, Kadota J, Kawakami K, Matsubara Y, Shirai R et al. Analysis of T cell subsets and beta chemokines in patients with pulmonary sarcoidosis. Thorax 1997 52 : 431 7.
19. Mukae H, Kohno S, Morikowa T, Kusano S, Kadota, J et al. Two-color analysis of lymphocyte subsets of bronchoalveolar lavage fluid and peripheral blood in Japanese patients with sarcoidosis. Chest 1994 105 : 1474 80.
20. Möller M, Aries SP, Drömann D, Mascher B, Braun J et al. Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis. Thorax 2001 56 : 487 93.